CSCO 2026 Global Perspectives | Professor William Gradishar: From Dual HER2 Blockade to the ADC Era—The Future and Transformation of HER2-Positive Breast Cancer Treatment
The 29th CSCO Academic Annual Meeting, jointly organized by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was grandly opened in Jinan, Shandong Province, from September 17 to 19, 2026. With the theme “Upholding Standards and Advancing Digital and Intelligent Innovation,” the annual meeting continued CSCO's longstanding mission of bringing together renowned oncology experts and scholars from around the world to share cutting-edge research findings and clinical experience. The meeting is expected to further advance cancer diagnosis and treatment in China and worldwide.









